Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify

Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify

Submitted by admin on December 22, 2020 - 11:29pm
Source: 
BioPharma Dive
News Tags: 
Vertex Pharmaceuticals
Skyhawk Therapeutics
small molecule drugs
M&A
Headline: 
Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify
snippet: 

Vertex will pay privately held biotech Skyhawk Therapeutics $40 million up front in a deal to develop small molecule drugs that can modify RNA and treat unspecified "serious diseases."

Do Not Allow Advertisers to Use My Personal information